Silo Pharma Inc.
SILO | NASDAQ
$1.23
-$0.02 (-1.60%)
At close: Oct 30, 2026, 4:00 PM ET
$1.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
-1.60%
(1D)No price chart data available for 1D timeframe.
Rating
22.8
+3.6 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #964/1028 (Top 94%)
Key Statistics
Market Data
Market Cap $1.39M
1D Range
1.20 1.25
52W Range
1.13 9.99
Valuation (TTM)
PE -0.23
PB 0.28
EV/EBITDA 0.88
Valuation (NTM)
Forward PE N/A
Forward PEG -0.08
Price Target $0.00
Cash Flow
FCF Yield -240.6%
SBC Adj. FCF Yield -250.6%
SBC Impact -4.2%
Margins
Gross Margin -474.3%
Operating Margin -8250.5%
FCF Margin -6176.8%
Growth (CAGR)
Revenue 3Y | 5Y -9.1% |
-6.0%
Dil EPS 3Y | 5Y 48.5% |
-68.7%
FCF 3Y | 5Y 2.6% |
-8.4%
Returns
ROA -75.1%
ROE -81.7%
ROIC -91.3%
Financial Health
Net Cash
$5.43M
Current Ratio 5.36
Interest Coverage -112.03
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric d...
Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Jan 8, 2021
Website silopharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SILO